News
FDA Grants Biosimilar Approval for HER2-Positive Breast Cancer
Pune, India | November 14, 2025 The U.S. Food and Drug Administration (FDA) approved Poherdy (pertuzumab-dpzb) as the inaugural interchangeable biosimilar to Perjeta (pertuzumab). This
Read More